Newsroom | 1633 results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jamaica: AHF Charters Miami Flight to Deploy Critical Hurricane Relief...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has been awarded the prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product for Yeztugo® (lenacapavir), the company’s twice-yearly injectable HIV-1 capsid inhibitor that provides adults and adolescents (≥35kg) at risk of HIV-1 acquisition with a new, highly effective option for pre-exposure prophylaxis (PrEP) for the prevention of HIV. The award, which recognizes outstanding pharmaceuti...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2025 results of operations. “We continue to deliver on Gilead's robust portfolio with a strong start for Yeztugo, rapidly growing uptake of Biktarvy, Descovy and Livdelzi, and positive data for Trodelvy in 1L metastatic triple negative breast cancer,” said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. “With multiple potential product launches in 2026, the strongest clinica...

WASHINGTON--(BUSINESS WIRE)--Victory! AHF, 100 Organizations Kill Gilead’s Greedy Drug Price Hikes...

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Equity on the Line: The PABS Annex and the Future of the Pandemic Agreement,” on Wednesday, October 29, 2025 at 10:00 AM EDT, virtually via Zoom. Register here. The Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement has entered a decisive phase, with Member States facing a compressed timeline to finalize the Pathogen Access a...

MENLO PARK, Calif.--(BUSINESS WIRE)--As millions of Americans track sleep and heart rate variability through wearable devices, ProDx Health is addressing the question those devices can't answer: what's actually causing the data to change. The Menlo Park-based diagnostic laboratory today announced its hormone testing service is now available nationwide, delivering testosterone, cortisol, and thyroid results in 48 hours – a significant improvement over the 7-10 day turnaround typical of tradition...

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Antimicrobial Resistance – A Global Health Security Crisis,” on Thursday, October 23, 2025 at 10:00 AM EDT, virtually via Zoom. Register here. This timely webinar will confront one of the most urgent yet underestimated threats to global health: antimicrobial resistance (AMR). Responsible for nearly five million deaths each year, AMR jeopardize...

WASHINGTON--(BUSINESS WIRE)--AHF: 80 Organizations Denounce Gilead on Price Hikes Gutting ADAP...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations across HIV, respiratory viruses, viral hepatitis, and viruses of pandemic potential including six oral presentations underscore Gilead’s leadership in advancing antiviral science and its ongoing efforts to bring forward innovative solutions for people and communit...

CIDADE DO MÉXICO--(BUSINESS WIRE)--O AHF Global Public Health Institute para a América Latina e Caribe, em parceria com o Instituto Nacional de Saúde Pública do México (INSP), convida a imprensa para a apresentação do relatório “Impacto previsto da ampliação do acesso ao Lenacapavir na América Latina”, realizado pelo INSP. O estudo modela o possível impacto que o acesso mais amplo ao lenacapavir — uma profilaxia pré-exposição injetável (PrEP) de ação prolongada administrada duas vezes ao ano —...